Skip to contents

Robert Burakoff
Professor of Medicine, Emeritus, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
75 Francis Street
Boston, MA 02115

Edit Profile

Albany medical School, 1972, MD

Publications (Pulled from Harvard Catalyst Profiles):

1. Qazi T, Verma R, Hamilton MJ, Kaplan ER, Redline S, Burakoff R. The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease. Inflamm Bowel Dis. 2019 May 04; 25(6):1044-1053.

2. Cohen-Mekelburg S, Rosenblatt R, Gold S, Shen N, Fortune B, Waljee AK, Saini S, Scherl E, Burakoff R, Unruh M. Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes. Am J Gastroenterol. 2019 Feb; 114(2):276-290.

3. Borges LF, Jagadeesan V, Goldberg H, Gavini S, Lo WK, Burakoff R, Feldman N, Chan WW. Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil. 2018 Jul 30; 24(3):395-402.

4. Cohen-Mekelburg S, Rosenblatt R, Gold S, Burakoff R, Waljee A, Saini S, Schackman BR, Scherl E, Crawford C. The Impact of Opioid Epidemic Trends on Hospitalized Inflammatory Bowel Disease Patients. J Crohns Colitis. 2018 May 07.

5. Lo WK, Goldberg HJ, Boukedes S, Burakoff R, Chan WW. Proton Pump Inhibitors Independently Protect Against Early Allograft Injury or Chronic Rejection After Lung Transplantation. Dig Dis Sci. 2018 Feb; 63(2):403-410.

6. Gavini S, Borges LF, Finn RT, Lo WK, Goldberg HJ, Burakoff R, Feldman N, Chan WW. Lung disease severity in idiopathic pulmonary fibrosis is more strongly associated with impedance measures of bolus reflux than pH parameters of acid reflux alone. Neurogastroenterol Motil. 2017 05; 29(5).

7. Winter RW, Burakoff R. How should we treat mild and moderate-severe Crohn's disease in 2017? A brief overview of available therapies. Expert Rev Gastroenterol Hepatol. 2017 Feb; 11(2):95-97.

8. Barnes EL, Burakoff R. New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes. Inflamm Bowel Dis. 2016 12; 22(12):2956-2965.

9. Burakoff R, MacDermott RP. Passing the Torch: Thank You from the Coeditors in Chief. Inflamm Bowel Dis. 2016 12; 22(12):2765-2766.

10. Hamilton MJ, Makrauer FM, Golden K, Wang H, Friedman S, Burakoff RB, Levine JS, Joshi P, Banks PA, Odze RD. Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis. Inflamm Bowel Dis. 2016 10; 22(10):2448-55.